519 672 2121
Close mobile menu

Testosterone therapy (or testosterone replacement therapy) is used to treat low testosterone levels, also known as hypogonadism or “low T,” in men. Prescription testosterone is available in several forms, including:

  • injections (Delatestryl or Depo-Testosterone)
  • gels or patches (Androgel)
  • pills (Andriol)

Testosterone Therapy Increases the Risk of Cardiovascular Complications

The class actions allege that the defendants failed to adequately warn patients and physicians that the use of testosterone therapy increases the risk of serious cardiovascular side effects, including heart attack, stroke, deep vein thrombosis, pulmonary embolism, and death.

Are You Eligible for Compensation?

Siskinds and Siskinds, Desmeules are representing individuals who have used testosterone therapy and suffered an adverse cardiovascular event.

If you were prescribed Testosterone Replacement Therapy and suffered from an adverse cardiovascular event, we encourage you to join Siskinds LLP’s Testosterone Replacement Therapy Class Actions.

Please complete the form below to receive updates on this case or call us toll-free, at 1-800-461-6166 (English) or 1-877-735-3842 (French).

Developments

On October 1, 2021, the Ontario Superior Court of Justice issued a judgement discontinuing the proposed Delatestryl class proceeding. A copy of the judgement rendered by the Ontario Superior Court of Justice authorizing the discontinuance, is available here . The Notice of Discontinuance can be found here (English) and here (French). The discontinuance relates to the proposed Delatestryl class action only. It does not relate to claims against various other manufacturers of testosterone replacement therapy products.

On July 14, 2021, the Ontario Superior Court of Justice issued a judgement discontinuing the proposed Andriol class proceeding. A copy of the judgement rendered by the Ontario Superior Court of Justice authorizing the discontinuance, is available here. The Notice of Discontinuance can be found here: EN and FR. The discontinuance relates to the proposed Andriol class action only. It does not relate to claims against various other manufacturers of testosterone replacement therapy products.

On June 21 2021, the Superior Court of Quebec issued a judgement discontinuing the motion for authorization in the Quebec class action concerning Andriol. A copy of the judgment rendered by the Superior Court of Quebec authorizing the discontinuance is available hereCopy of the notice of discontinuance is available here (English and French). The discontinuance relates to the proposed Andriol class action in Quebec only.

On October 30, 2019, the Ontario Superior Court of Justice issued a judgement discontinuing  the proposed Depo-Testosterone class proceeding.  A copy of the judgement rendered by the Ontario Superior Court of Justice authorizing the discontinuance, is available here. The Notice of Discontinuance can be found here: EN and FR. The discontinuance relates to the proposed Depo-Testosterone class action only. It does not relate to claims against various other manufacturers of testosterone replacement therapy products.

On November 23, 2016, the Ontario Superior Court of Justice issued a judgement dismissing a proposed class action alleging that AndroGel, a form of testosterone replacement therapy (“TRT”), causes serious cardiovascular events, including heart attacks and strokes. Click here for the reasons the Court dismissed the action.

While the Court’s judgement is limited in application to the Plaintiff, who was prescribed AndroGel, the decision may influence other TRT litigation.

On September 21, 2015, Siskinds, Desmeules, the Quebec firm affiliated with Siskinds LLP commenced a class action in Quebec for Andriol (testosterone capsule).

In 2014, Siskinds LLP commenced class actions arising from two different forms of TRT:

  • Delatestryl (testosterone injection)
  • Andriol (testosterone capsule)

FAQs

What is a class action?

A class action is a lawsuit that is brought by one or more persons on behalf of a larger group of people whose claims share common legal and/or factual issues. Class actions provide a cost-effective way for groups of people with common interests to pursue a legal claim.

What does “certification” mean?

Certification is the motion where the court determines whether the action can properly be pursued as a class action. The court will consider factors such as whether the claims of the class members raise common legal and/or factual issues and whether a class action is the preferable method of pursuing the claims (as opposed to other methods, such as individual actions).

Do I have to pay anything to participate in the class action?

Class action lawyers are usually paid on a contingency basis. This means that class counsel are only paid if successful. Class counsel are paid a percentage of any settlement or court award. Class counsel fees are subject to court approval.

Who is affected by the testosterone therapy class action?

You are affected by the class action and are a “member” of the class if you used a testosterone therapy and experienced a cardiovascular side effect, including heart attack, stroke, deep vein thrombosis, pulmonary embolism, and death.

What should I do to protect my rights?

To protect your rights, you should:

  • Keep a record of medical expenses incurred—appointments not covered by your provincial health care provider, prescriptions, medical devices, etc.
  • Keep a record of all medical treatments, including the names and contact information of the health care provider (doctor, surgeon, physiotherapist etc.).
  • If possible, keep a journal of symptoms and note down any times when you are unable to attend work or school as a result of your symptoms.

If you have not done so already, contact Siskinds in order that we can contact your health care providers to obtain relevant medical and pharmacy records. As time passes, it can be more difficult to collect this information. All personal information provided to Siskinds regarding your Testosterone Therapy use and any injuries/symptoms you may have suffered from as a result of taking Testosterone Therapy will be kept private and confidential.

I still have a question. Who should I contact?

If you have any other questions, please complete the contact form below or call 1-800-461-6166 for English inquiries or 1-877-735-3842 for French inquiries.

On October 1, 2021, the Ontario Superior Court of Justice issued a judgement discontinuing the proposed Delatestryl class proceeding. A copy of the judgement rendered by the Ontario Superior Court of Justice authorizing the discontinuance, is available here . The Notice of Discontinuance can be found here (English) and here (French). The discontinuance relates to the proposed Delatestryl class action only. It does not relate to claims against various other manufacturers of testosterone replacement therapy products.

On July 14, 2021, the Ontario Superior Court of Justice issued a judgement discontinuing the proposed Andriol class proceeding. A copy of the judgement rendered by the Ontario Superior Court of Justice authorizing the discontinuance, is available here. The Notice of Discontinuance can be found here: EN and FR. The discontinuance relates to the proposed Andriol class action only. It does not relate to claims against various other manufacturers of testosterone replacement therapy products.

On June 21 2021, the Superior Court of Quebec issued a judgement discontinuing the motion for authorization in the Quebec class action concerning Andriol. A copy of the judgment rendered by the Superior Court of Quebec authorizing the discontinuance is available hereCopy of the notice of discontinuance is available here (English and French). The discontinuance relates to the proposed Andriol class action in Quebec only.

On October 30, 2019, the Ontario Superior Court of Justice issued a judgement discontinuing  the proposed Depo-Testosterone class proceeding.  A copy of the judgement rendered by the Ontario Superior Court of Justice authorizing the discontinuance, is available here. The Notice of Discontinuance can be found here: EN and FR. The discontinuance relates to the proposed Depo-Testosterone class action only. It does not relate to claims against various other manufacturers of testosterone replacement therapy products.

On November 23, 2016, the Ontario Superior Court of Justice issued a judgement dismissing a proposed class action alleging that AndroGel, a form of testosterone replacement therapy (“TRT”), causes serious cardiovascular events, including heart attacks and strokes. Click here for the reasons the Court dismissed the action.

While the Court’s judgement is limited in application to the Plaintiff, who was prescribed AndroGel, the decision may influence other TRT litigation.

On September 21, 2015, Siskinds, Desmeules, the Quebec firm affiliated with Siskinds LLP commenced a class action in Quebec for Andriol (testosterone capsule).

In 2014, Siskinds LLP commenced class actions arising from two different forms of TRT:

  • Delatestryl (testosterone injection)
  • Andriol (testosterone capsule)

What is a class action?

A class action is a lawsuit that is brought by one or more persons on behalf of a larger group of people whose claims share common legal and/or factual issues. Class actions provide a cost-effective way for groups of people with common interests to pursue a legal claim.

What does “certification” mean?

Certification is the motion where the court determines whether the action can properly be pursued as a class action. The court will consider factors such as whether the claims of the class members raise common legal and/or factual issues and whether a class action is the preferable method of pursuing the claims (as opposed to other methods, such as individual actions).

Do I have to pay anything to participate in the class action?

Class action lawyers are usually paid on a contingency basis. This means that class counsel are only paid if successful. Class counsel are paid a percentage of any settlement or court award. Class counsel fees are subject to court approval.

Who is affected by the testosterone therapy class action?

You are affected by the class action and are a “member” of the class if you used a testosterone therapy and experienced a cardiovascular side effect, including heart attack, stroke, deep vein thrombosis, pulmonary embolism, and death.

What should I do to protect my rights?

To protect your rights, you should:

  • Keep a record of medical expenses incurred—appointments not covered by your provincial health care provider, prescriptions, medical devices, etc.
  • Keep a record of all medical treatments, including the names and contact information of the health care provider (doctor, surgeon, physiotherapist etc.).
  • If possible, keep a journal of symptoms and note down any times when you are unable to attend work or school as a result of your symptoms.

If you have not done so already, contact Siskinds in order that we can contact your health care providers to obtain relevant medical and pharmacy records. As time passes, it can be more difficult to collect this information. All personal information provided to Siskinds regarding your Testosterone Therapy use and any injuries/symptoms you may have suffered from as a result of taking Testosterone Therapy will be kept private and confidential.

I still have a question. Who should I contact?

If you have any other questions, please complete the contact form below or call 1-800-461-6166 for English inquiries or 1-877-735-3842 for French inquiries.

Contact Us

There Was An Error